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Abstract
Background: Fast-track surgery (FTS), also known as enhanced recovery after surgery, is a multidisciplinary approach
to accelerate recovery, reduce complications, minimise hospital stay without increasing readmission rates, and reduce
health care costs, all without compromising patient safety. The advantages of FTS in abdominal surgery most likely
extend to gynaecological surgery, but this is an assumption, as FTS in elective gynaecological surgery has not been
well studied. No consensus guidelines have been developed for gynaecological oncological surgery although surgeons
have attempted to introduce slightly modified FTS programmes for patients undergoing such surgery. To our
knowledge, there are no published randomised controlled trials; however, some studies have shown that FTS
in gynaecological oncological surgery leads to early hospital discharge with high levels of patient satisfaction.
The aim of this study is whether FTS reduces the length of stay in hospital compared to traditional management. The
secondary aim is whether FTS is associated with any increase in post-surgical complications compared to traditional
management (for both open and laparoscopic surgery).
Methods/design: This trial will prospectively compare FTS and traditional management protocols. The primary
endpoint is the length of post-operative hospitalisation (days, mean ± standard deviation), defined as the number
of days between the date of discharge and the date of surgery. The secondary endpoints are complications in
both groups (FTS versus traditional protocol) occurring during the first 3 months post-operatively including
infection (wound infection, lung infection, intraperitoneal infection), post-operative nausea and vomiting, ileus,
post-operative haemorrhage, post-operative thrombosis, and the Acute Physiology and Chronic Health Enquiry II score.
Discussion: The advantages of FTS most likely extend to gynaecology, although, to our knowledge, there are no
randomised controlled trials. The aim of this study is to compare the post-operative length of hospitalisation after
major gynaecological or gynaecological oncological surgery and to analyse patients’ post-operative complications. This
trial may reveal whether FTS leads to early hospital discharge with few complications after gynaecological surgery.
Trial registration number: NCT02687412. Approval Number: SCCHEC20160001. Date of registration: registered on 23
February 2016.
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Background
Fast-track surgery (FTS), also known as enhanced recov-
ery after surgery, was initiated in 1995 by Bardram et al.
[1]. FTS is a multidisciplinary approach to accelerate re-
covery, reduce complications, minimise hospital stay with-
out increasing re-admission rates, and reduce healthcare
costs, all without compromising patient safety [2]. FTS
has been adopted by gynaecological, colorectal and upper
GI specialities worldwide, and has been used successfully
in non-malignant gynaecological surgery [3, 4], and is
especially effective in elective colorectal surgery [5-7].
The speed of post-operative recovery is influenced by
multiple factors including pain, post-operative nausea
and vomiting (PONV), paralytic ileus, fatigue, and sleep
disturbances. A multimodal approach to prevent and
minimise these factors is considered essential to en-
hance recovery [2, 5, 6, 8]. Fast-track principles include
providing the patient with thorough pre-operative in-
formation and education concerning pre-, intra- and
post-operative care, the use of safe and short-acting an-
aesthetics, optimal dynamic pain relief with minimal
use of opioids, management of PONV, enteral nutrition
and early mobilisation, and the use of minimally inva-
sive surgery [9].
The advantages of FTS documented in abdominal
surgery most likely extend to gynaecological surgery;
however, this is an assumption because FTS in elect-
ive gynaecological surgery has not been well studied.
One study has shown that FTS in gynaecological
oncology provides early hospital discharge and high
levels of patient satisfaction [10]. However, no con-
sensus guidelines have been developed for gynaeco-
logical oncological surgery although surgeons have
attempted to introduce slightly modified FTS pro-
grammes for patients undergoing such surgery. To
our knowledge, no randomised controlled trials have
been published [3, 11, 12].
In traditional surgical care, patients are often admitted
to hospital the day before the planned surgery, undergo
pre-operative mechanical and antibiotic bowel prepar-
ation, and receive ongoing intravenous fluids to maintain
fluid balance prior to surgery or anaesthesia. Intra-
operatively, patients are often volume-loaded to main-
tain filling pressures, receive pelvic drains to prevent
fluid collection, then spend 2–3 days nil by mouth
until bowel sounds return before beginning a gradu-
ated diet of clear liquids, free fluids, light diet, and fi-
nally a regular diet 5–7 days post-surgery. Patients are
discharged an average of 5–7 days post-surgery [13].
FTS or enhanced surgical recovery programmes have
been developed and refined in many specialities with
documented improved patient outcomes, earlier dis-
charge from hospital, and reduced post-operative
length of stay (LOS) [2, 14, 15].
The aim of this study is to analyse the post-surgical
complications in patients receiving FTS who are dis-
charged earlier than anticipated after major gynaeco-
logical or gynaecological oncological surgery.
Methods/design
Objectives and hypothesis
This prospective study will compare FTS and traditional
management protocols and test the following hypotheses:
H0: length of stay and post-operative complications
are equal in both groups.
H1: length of stay is enhanced in the FTS group and
post-operative complications differ between groups.
Study population and eligibility criteria
The trial is designed as a randomised, controlled, non-
blinded, single-centre trial in the Department of Gynae-
cological Oncology of the Si Chuan Cancer Hospital
Chengdu, Sichuan, China.
Inclusion criteria
1. Patients scheduled for gynaecological oncology
surgery (including radical hysterectomy and
lymphadenectomy, hysterectomy and
lymphadenectomy, and cytoreductive procedures
for both open and laparoscopic surgery);
2. Age: ≥ 18 years;
3. Signed informed consent provided.
Exclusion criteria
1. Patients with a documented infection at the time
of surgery;
2. Age ≥ 71 years;
3. Patients with ileus at the time of surgery;
4. Patients with hypocoagulability;
5. Patients with psychological disorders, alcohol
dependence, or drug abuse history;
6. Patients with primary nephrotic or hepatic
disease;
7. Patients with severe hypertension defined as systolic
blood pressure ≥ 160 mmHg and diastolic blood
pressure > 90 mmHg.
Criteria for discontinuing
1. The trial appears to be causing unexpected harm
or severe adverse events to participants, or
evidence that the risks outweigh the benefits,
with a discontinuance decision from the ethics
committee.
2. The enrollment indicates the trial cannot be
completed in the 3-month period.
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Sample size calculation
The sample size calculation is based on the LOS with a
standard deviation in the traditional group of 1.5 based
on previous studies [16, 17].
We estimate that in a superiority trial with an effect
size of 90% and a margin of 10 (alpha 5%, power 90%)
where μα = 1.96 and μβ = 1.28, using the equation n
= [2(μα + μβ) σ /δ]2, a sample size of 47 patients per
group is necessary to detect a difference between the
groups. With an expected dropout rate of 20%, we plan
to enrol 120 patients in the study.
Method of generating the allocation sequence
Computer-generated random numbers and list of any
factors for stratification. To reduce predictability of a
random sequence, details of any planned restriction (e.g.
blocking) should be provided in a separate document
that is unavailable to those who enrol participants or
assign interventions.
Post-operative data collection
A daily assessment of the study patients will be made by
clinical investigators or a delegated physician. Patients
will be randomised when the surgery is booked. All
protocol-required information collected during the
trial will be entered into the patient’s record inclu-
ding: (1) patient characteristics, (2) hospitalisation in-
formation, (3) post-operative information, and (4)
complications. Patient characteristics data will include:
age, weight, height, body mass index, medical insu-
rance status, blood pressure, glycaemia, lipidemia and
performance status. Hospitalisation details will include
LOS, the procedure performed, diagnosis, operating
time, and intra-operative estimated blood loss. Post-
operative details will include time to full tolerance of
free fluids (days), time to full tolerance of solid food
(days), and time to drain removal (days), admission to
ICU, return to operating room, blood transfusion,
venous thromboembolism (VTE), readmission to
hospital, and malignancy status and hospitalisation
expenses.
Complications (Table 1) details will include infection
(wound infection, lung infection, intraperitoneal infec-
tion), PONV, ileus, post-operative haemorrhage, post-
operative thrombosis, and Acute Physiology and Chronic
Health Enquiry (APACHE) II score (Table 2).
Table 1 Checklist of fast track and traditional management
Allocation FTS management Traditional management
Computer-generated random numbers Computer-generated random numbers
Pre-operative
Pre-operative assessment, counselling and FT management education No FT management education
Information on the fast-track treatment and informed consent Information on traditional treatment and informed consent
Pre-operative nutritional drink up to 4 h prior to surgery (TPF-D produced by
FreseniusKabi Deutschland GmbH, Bad Homburg, Germany). Fasting - solid
food 6 h before and liquid food intake of clear fluids 2 h before anaesthesia
Pre-operative fasting at least 8 h
Patients do not receive mechanical bowel preparation, only oral intestinal
cleaner 12 h pre-operation can be accepted, but no need of liquid stool
Oral bowel preparation or mechanical bowel preparation
until liquid stool
Anti-microbial prophylaxis and skin preparation Anti-microbial prophylaxis and skin preparation
Pre-operative treatment with carbohydrates (10% glucose 400 ml orally
2–3 h before operation) (patients without diabetes)
No oral intake on the operation day
Intra-operative
Avoiding hypothermia, keeping the intra-operative core temperature
at 36 ± 0.5 °C
Keeping the intra-operative core temperature at
34.7 ± 0.6 °C
Anti-emetics at end of anaesthesia Not every patient gets anti-emetics at end of
anaesthesia
Post-operative
Post-operative glycaemic control Post-operative glycaemic control only with diabetes
Preventive post-operative nausea and vomiting (PONV) control Post-operative nausea and vomiting (PONV) control when
it happens
Early post-operative diet (3–6 h after surgery, patients resume a liquid
diet, 12 h after surgery patients begin to take solid diet)
6 h after surgery, patients resume a liquid diet, patients
begin to take solid diet after anal exhaust
Early mobilisation Early mobilisation
Time to drain removal less than 24 h (eliminate post-operative bleeding
and urinary fistula, intestinal fistula)
Time to drain removal less than 48 h (eliminate post-
operative bleeding and urinary fistula, intestinal fistula)
Audit Systematic audit improves compliance and clinical outcomes
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Primary and secondary endpoints
Primary endpoints
LOS (days (d), mean ± standard deviation (SD)), which is
defined as the number of days between the date of
discharge and the date of surgery.
Secondary endpoints
Complications: complications in both groups are
assessed during the first 21 days hospitalisation expenses
post-operatively and include infection (wound infection,
lung infection, intraperitoneal infection), PONV, ileus,
post-operative haemorrhage, post-operative thrombosis,
and APACHE II score (Table 2).
Ethics, study registration and consent
This trial was approved by an independent ethics
committee at Sichuan Cancer Hospital and Research
Institute.
Board Affiliation: Sichuan CHRI
Telephone: +86 02885420681; email: scchgcp@163.com
The study procedures, risks, benefits and data manage-
ment will be discussed with patients before they are
asked to provide informed consent to participate.
Study treatment
The surgical technique is standardised for the treatment
team, and patients’ families are not blinded to the study.
Data collectors are not involved in the clinical manage-
ment of patients to ensure statistical validity and reliabil-
ity. All surgeries are performed by the same team of
surgeons, and patients are treated and nursed by the same
treatment team during the pre-operative period. Post-
operative complications are based on patient complaints
and clinical symptoms. Given that there are no FTS guide-
lines for gynaecological oncological surgery, we refer to
the guidelines for gastrectomy, colorectal surgery, and
pancreaticoduodenectomy (Table 2 and Fig. 1) [18–20].
Safety
Gynaecological oncological surgery is highly technically
demanding. To avoid bias based on the surgical learning
curve, every surgical procedure will be performed or su-
pervised by a senior surgeon. Informed consent will be
obtained from all participants.
Methods for avoiding bias
Minimising systemic bias
Patients will be randomised to one of the two groups
after admission. Randomisation will be accomplished
using balanced permutation blocks by generating ran-
dom numbers to obtain homogeneity between groups.
Opaque, sealed envelopes will be labelled with the ran-
domisation number and will contain a sheet stating
the group allocation for the patient. Randomisation
envelopes will be used in consecutive order. Basic pa-
tient characteristics and the day of randomisation will
be documented on a data sheet so that compliance to
the randomisation scheme can be checked retrospect-
ively. If patients are excluded from the study after
randomisation, their numbers will not be reused. Op-
erating surgeons, attending physicians, nursing staff,
and patients and families cannot be blinded in this
study, as the procedures differ between groups; how-
ever, outcome assessors will not be blinded. The
randomisation process will follow the CONSORT
guidelines (Fig. 2) [21].
Minimising treatment bias
Gynaecological oncological surgery (including radical
hysterectomy and lymphadenectomy, hysterectomy and
lymphadenectomy, and cytoreductive procedures) are
Table 2 Clinical parameters and post-operative complications for analysis
Parameters Definitions
Patient characteristics Age, weight, height, body mass index (BMI), medical insurance status and performance status
Hospitalisation LOS (length of hospitalisation post-operation), the procedure performed, diagnosis, operating
time, name of surgery, intra-operative estimated blood loss
Post-operation Time to full tolerance of free fluids (days), time to full tolerance of solid food (days), time to
drain removal (days) hospitalisation expenses
Complications
Infection Wound infection, lung infection, intraperitoneal infection, operation space infection (fever, mild
abdominal pain without radiographic abnormalities)
Post-operative nausea and vomiting
(PONV)
It was recognised that nausea and vomiting are common side effects of surgical recovery
Ileus Is a disruption of the normal propulsive ability of the gastrointestinal tract
Post-operative haemorrhage Evidence of blood loss from drains or based on ultrasonography
Post-operative thrombosis Evidence of blood thrombosis based on ultrasonography
APACHE II score Acute Physiology and Chronic Health Evaluation II
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Fig. 1 Content for the schedule of enrollment, intervention, and assessments
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standardised in both groups, and all surgeons participat-
ing in the study are familiar with these procedures,
which are commonly and routinely performed, thus
eliminating a learning curve.
Minimising measurement bias
LOS and post-operative complications, which are the
primary and secondary endpoints, will be based on data
in the patient’s record. Blinding is not necessary, because
the LOS is an objective endpoint that cannot be influ-
enced by the patient. Physician blinding is not possible
because they perform the surgery.
Patient pathway
All the patients in the trial will go through as depicted
in the flowchart (Fig. 2).
Statistical methods
Each patient’s allocation to the analysed population
will be defined prior to the analysis and will be doc-
umented. In the full analysis set, patients will be
analysed as randomised according to the intention-
to-treat principle. The intention-to-treat principle
implies that the analysis includes all randomised pa-
tients. The per protocol analysis set will include all
patients without major protocol deviation. Deviations
from the protocol will be assessed as major or
minor, and patients with major deviations from the
protocol will be excluded from the per protocol ana-
lysis. The safety analysis set will analyse patients ac-
cording to the treatment.
The null hypothesis assumes that LOS and post-
operative complications are equal in both groups. A binary
logistic regression will be used to compare LOS between
groups while adjusting for other factors.
Data will be analysed using SPSS 19.0 (IBM Corp.,
Armonk, NY, USA) and expressed as mean ± SD. LOS
in the FTS and traditional groups will be compared
and analysed using the Mann-Whitney U test (non-
normal distribution). NRS2002 scores between the
two groups will be analysed using Wilcoxon’s test
(non-normal distribution) or Student’s t test (normal
distribution). The chi-square test or Fisher’s exact test
will be used to analyse the categorical secondary end-
points (complications). P < 0.05 will be considered sta-
tistically significant.
Discussion
FTS has been adopted by most surgical specialties
worldwide; however, few studies have assessed FTS in
gynaecological malignant surgery [22], and there are
currently no randomised controlled trials to support or
refute this approach [11]. To our knowledge, no consen-
sus guidelines have been developed for gynaecological
oncological surgery although surgeons have attempted
to introduce slightly modified FTS programmes for
patients undergoing such surgery [3, 11, 12].
Widespread education is needed to improve the rate
of implementation of FTS. There are several possible
reasons for the lack of implementation including a lack
of collaboration within surgical teams and a lack of
awareness of or failure to accept and adopt evidence-
based findings [8, 9, 23]. Close cooperation between the
surgical, anaesthestic, and nursing staff is essential, and
the importance of cooperation cannot be overestimated
as practice using FTS is needed to achieve further devel-
opments in surgical care and post-operative recovery
[24, 25]. Fast-track regimens have been well evaluated,
generally, regarding medical complications, and they
appear to be safe [26].
The aim of this study is to compare LOS and to analyse
post-operative complications after major gynaecological
or gynaecological oncological surgery. This trial may re-
veal whether FTS results in early hospital discharge and
low complication rates after gynaecological surgery.
Trial status
At the time of writing, we are about to enrol patients,
and the anticipated study completion date is May 2017.
Abbreviations
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track surgery; LOS: postoperative length of hospitalisation; PONV: postoperative
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